20 (AIDX) Current Leases (2024 - 2026)

20's (AIDX) quarterly Current Leases came in at $189649.0 in Q1 2026, up 7.79% on a QoQ basis from $175948.0 in Q4 2025.

20 (AIDX) Current Leases (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Current Leases data on file, last reported at $189649.0 in Q1 2026.

Quarterly Current Leases changed N/A year-over-year to $189649.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $189649.0 (changed N/A YoY) and the FY2025 annual result came in at $175948.0, up 6.18% from the prior year.
Current Leases climbed to $189649.0 in Q1 2026, from $175948.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $189649.0 in Q1 2026 to a low of $165702.0 in Q4 2024.
A 3-year average of $177099.7 and a median of $175948.0 in 2025 frame the typical range for Current Leases.
The widest YoY moves for Current Leases: up 6.18% in 2025, down 6.18% in 2025.
Tracing AIDX's Current Leases over 3 years: stood at $165702.0 in 2024, then increased by 6.18% to $175948.0 in 2025, then rose by 7.79% to $189649.0 in 2026.
The last three Current Leases figures came in at $189649.0 (Q1 2026), $175948.0 (Q4 2025), and $165702.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	-
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	-
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	-
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	24.10 Mn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	20.70 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	-
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	-
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	35.60 Mn
10	20	5.55 Mn	1.00 Mn	304,727.00	192,731.00

Download Data